Our Services

We offer comprehensive corporate finance advisory services, guiding companies from market entry through growth consultancy to successful exits.

BUSINESS READINESS

Prepare for investors with our tailored service: pitch deck review, technology valuation, financial modelling, and data room review for confident and effective presentations.

IP VALUATION

Specialised valuation services for non-income generating biotech ventures, assessing technologies without revenue or profitability.

R&D TAX INCENTIVE - AUSTRALIA

Expert valuation and licensing support tailored for R&D tax incentives in Australia. We ensure compliance with ATO requirements for robust agreements between overseas parents and Australian subsidiaries, validating values and providing comprehensive licensing agreement support.

CAPITAL RAISE

Comprehensive support including pitch deck preparation, investor list creation, outreach, and negotiation of investment terms.

LICENSING

Preparation and structuring of licensing agreements to maximise long-term benefits/value. This includes modelling and negotiating licensing terms such as the split of value into upfronts, milestone payments and royalties.

SELL-SIDE ADVISORY

Guidance and support for companies looking to sell their business or assets. Sell-side M&A.

MANAGEMENT BUYOUT

Assistance and strategic guidance for management teams acquiring their company from existing owners.

IPO

Comprehensive advisory and support for companies preparing to go public, from initial planning to market debut.

DIRECTORSHIP

We offer directorship services tailored for biotech companies, providing strategic oversight and industry expertise.

STRATEGIC CONSULTING

Customised advisory services optimising business strategies and growth opportunities. We analyse financial structures, and technologies, and develop strategies to maximise value extraction. This includes prioritising technology development, optimising commercialisation pathways, and determining the most capital-efficient mix (licensing, capital raises, M&A, IPO) to advance technologies.

Our mission is to ensure that potentially game-changing research reaches its full potential in the market. That’s why we are on a crusade to provide early- and clinical-stage life science companies access to the same strategic financial advice - including valuation and licensing capability - that is available for the big pharma.

Let’s talk!

Let's start the conversation and explore how we can catalyse your success in the competitive biotech landscape.

Sherwood Global Partners | North America | Europe | Asia | Australia